β1 integrin deletion enhances progression of prostate cancer in the TRAMP mouse model

被引:16
|
作者
Moran-Jones, Kim [1 ]
Ledger, Anita [1 ]
Naylor, Matthew J. [1 ,2 ,3 ]
机构
[1] St Vincents Hosp, Garvan Inst Med Res, Canc Res Program, Darlinghurst, NSW 2010, Australia
[2] Univ Sydney, Sch Med Sci, Discipline Physiol, Sydney, NSW 2006, Australia
[3] Univ Sydney, Sch Med Sci, Bosch Inst, Sydney, NSW 2006, Australia
来源
SCIENTIFIC REPORTS | 2012年 / 2卷
基金
英国医学研究理事会;
关键词
BETA(1A) INTEGRIN EXPRESSION; ALPHA(2)BETA(1) INTEGRIN; TERMINAL DIFFERENTIATION; 3-DIMENSIONAL CULTURES; CELL-PROLIFERATION; TRANSGENIC MOUSE; MAMMARY-GLAND; IN-VIVO; GROWTH; PROTEIN;
D O I
10.1038/srep00526
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
beta 1 integrin regulates the response of both normal and cancer cells to their local environment. Although mis-localised in prostate cancer, the role beta 1 integrin plays in prostate development and carcinogenesis remains unknown. To assess the role of beta 1 integrin in vivo, we conditionally deleted beta 1 integrin from prostate epithelium and subsequently crossed these mice to the TRAMP prostate carcinogenesis model. Deletion of beta 1 integrin following castration and subsequent androgen supplementation resulted in an expansion of the p63-positive basal cell population and decreased differentiation. Consistent with these findings, deletion of beta 1 integrin in TRAMP mice decreased animal survival, decreased retention of normal prostate morphology, increased the percentage of tissue with poorly differentiated carcinoma, and increased cell proliferation. This study demonstrates that beta 1 integrin regulates several aspects of normal prostate development and in contrast to its role in several other tissues, its loss is associated with increased rates of prostate tumour progression.
引用
下载
收藏
页数:7
相关论文
共 50 条
  • [31] X-linked inhibitor of apoptosis deficiency in the TRAMP mouse prostate cancer model
    Hwang, C.
    Oetjen, K. A.
    Kosoff, D.
    Wojno, K. J.
    Albertelli, M. A.
    Dunn, R. L.
    Robins, D. M.
    Cooney, K. A.
    Duckett, C. S.
    CELL DEATH AND DIFFERENTIATION, 2008, 15 (05): : 831 - 840
  • [32] Will metformin postpone high-fat diet promotion of TRAMP mouse prostate cancer development and progression?
    Hua Xu
    Meng-bo Hu
    Pei-de Bai
    Wen-hui Zhu
    Qiang Ding
    Hao-wen Jiang
    International Urology and Nephrology, 2014, 46 : 2327 - 2334
  • [34] Lack of a low-dose radiation adaptive response on prostate cancer progression in the TRAMP model
    Sykes, Pamela
    Ormsby, Rebecca
    Blyth, Benjamin
    Bezak, Eva
    Newman, Michelle
    Tilley, Wayne
    Lawrence, Mark
    BJU INTERNATIONAL, 2013, 112 : 39 - 39
  • [35] Increased fatty acid synthase expression and activity during progression of prostate cancer in the TRAMP model
    Pflug, BR
    Pecher, SM
    Brink, AW
    Nelson, JB
    Foster, BA
    PROSTATE, 2003, 57 (03): : 245 - 254
  • [36] Impact of two types of obesity on prostate cancer in the TRAMP mouse
    Bonorden, Melissa
    Grossmann, Michael
    Rogozina, Olga
    Liao, D.
    Grande, Joseph
    Cleary, Margot
    CANCER RESEARCH, 2009, 69
  • [37] AsialoGM1 and integrin α2β1 mediate prostate cancer progression
    Van Slambrouck, Severine
    Hilkens, John
    Bisoffi, Marco
    Steelant, Wim F. A.
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2009, 35 (04) : 693 - 699
  • [39] Systemic alkalinisation delays prostate cancer cell progression in TRAMP mice
    Astigiano, Simonetta
    Puglisi, Andrea
    Mastracci, Luca
    Fais, Stefano
    Barbieri, Ottavia
    JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY, 2017, 32 (01) : 363 - 368
  • [40] Characterization of the FGF axis and identification of a novel FGFR1iiic isoform during prostate cancer progression in the TRAMP model
    Foster B.A.
    Kaplan P.J.
    Greenberg N.M.
    Prostate Cancer and Prostatic Diseases, 1999, 2 (2) : 76 - 82